Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).

Rozen R.

Thromb Haemost. 1997 Jul;78(1):523-6. Review. No abstract available.

PMID:
9198208
[PubMed - indexed for MEDLINE]
2.

Genetic modulation of homocysteinemia.

Rozen R.

Semin Thromb Hemost. 2000;26(3):255-61. Review.

PMID:
11011843
[PubMed - indexed for MEDLINE]
3.

[Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].

Spiridonova MG, Stepanov VA, Puzyrev VP.

Klin Med (Mosk). 2001;79(2):10-6. Review. Russian. No abstract available.

PMID:
11419077
[PubMed - indexed for MEDLINE]
4.

Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease.

Brattström L.

Circulation. 1997 Nov 18;96(10):3805-7. No abstract available.

PMID:
9396508
[PubMed - indexed for MEDLINE]
5.

Hyperhomocysteinemia, MTHFR, and risk of vascular disease.

Blom HJ, Verhoef DP.

Circulation. 2000 Apr 25;101(16):E171; author reply E173. No abstract available.

PMID:
10779473
[PubMed - indexed for MEDLINE]
Free Article
6.

The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.

Haviv YS, Shpichinetsky V, Goldschmidt N, Atta IA, Ben-Yehuda A, Friedman G.

Nephron. 2002 Sep;92(1):120-6.

PMID:
12187094
[PubMed - indexed for MEDLINE]
7.

Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.

Morimoto K, Haneda T, Okamoto K, Ishida H, Kikuchi K.

Nephron. 2002 Jan;90(1):43-50.

PMID:
11744804
[PubMed - indexed for MEDLINE]
8.

MTHFR gene polymorphism, homocysteine and cardiovascular disease.

Cortese C, Motti C.

Public Health Nutr. 2001 Apr;4(2B):493-7. Review.

PMID:
11683544
[PubMed - indexed for MEDLINE]
9.

Methylenetetrahydrofolate reductase gene and coronary artery disease.

Mager A.

Circulation. 2000 Apr 25;101(16):E172-3. No abstract available.

PMID:
10779474
[PubMed - indexed for MEDLINE]
Free Article
10.

Homocysteine and cardiovascular risk.

Scott JM.

Am J Clin Nutr. 2000 Aug;72(2):333-4. No abstract available.

PMID:
10919922
[PubMed - indexed for MEDLINE]
Free Article
11.

The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.

Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, Eckfeldt JH, Rozen R.

Atherosclerosis. 2001 Jun;156(2):409-15.

PMID:
11395038
[PubMed - indexed for MEDLINE]
12.

Recent data are not in conflict with homocysteine as a cardiovascular risk factor.

Refsum H, Ueland PM.

Curr Opin Lipidol. 1998 Dec;9(6):533-9. Review.

PMID:
9868588
[PubMed - indexed for MEDLINE]
13.

Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?

Ashfield-Watt PA, Moat SJ, Doshi SN, McDowell IF.

Biomed Pharmacother. 2001 Oct;55(8):425-33. Review.

PMID:
11686575
[PubMed - indexed for MEDLINE]
14.

V677 mutation of methylenetetrahydrofolate reductases and cardiovascular disease in Canadian Inuit.

Hegele RA, Tully C, Young TK, Connelly PW.

Lancet. 1997 Apr 26;349(9060):1221-2. No abstract available.

PMID:
9130949
[PubMed - indexed for MEDLINE]
15.

Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.

Domagala TB, Adamek L, Nizankowska E, Sanak M, Szczeklik A.

Blood Coagul Fibrinolysis. 2002 Jul;13(5):423-31.

PMID:
12138370
[PubMed - indexed for MEDLINE]
16.

Hyperhomocysteinemia: another independent vascular risk factor.

Deleu D.

Saudi Med J. 2000 Aug;21(8):787-8. No abstract available.

PMID:
11423902
[PubMed - indexed for MEDLINE]
17.

Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project.

Meleady R, Ueland PM, Blom H, Whitehead AS, Refsum H, Daly LE, Vollset SE, Donohue C, Giesendorf B, Graham IM, Ulvik A, Zhang Y, Bjorke Monsen AL; EC Concerted Action Project: Homocysteine and Vascular Disease.

Am J Clin Nutr. 2003 Jan;77(1):63-70.

PMID:
12499324
[PubMed - indexed for MEDLINE]
Free Article
18.

Serum homocysteine, folate and thermolabile variant of MTHFR in healthy Sri Lankans living in London.

Alagratnam D, Wierzbicki AS, Swaminathan R, Turner C, Wickramasinghe SN.

Atherosclerosis. 2000 Mar;149(1):221-2. No abstract available.

PMID:
10799015
[PubMed - indexed for MEDLINE]
19.

Homocysteine screening of a female Hispanic population.

Wu AH, Holtman V, Tsongalis GJ, Macer J.

Int J Mol Med. 1999 Sep;4(3):295-7.

PMID:
10425282
[PubMed - indexed for MEDLINE]
20.

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis.

Brattström L, Wilcken DE, Ohrvik J, Brudin L.

Circulation. 1998 Dec 8;98(23):2520-6.

PMID:
9843457
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk